Ver­tex gets more pre­cise with Ar­bor in ex­pand­ed gene edit­ing pact

Feng Zhang’s Ar­bor Biotech­nolo­gies is ex­pand­ing its al­liance with Ver­tex Phar­ma­ceu­ti­cals, but is stay­ing mum on fi­nan­cials this time around.

The CRISPR gene edit­ing start­up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER